Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
Clinical trial NCT06654700 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06654700
- Sponsor
- MAXVAX Biotechnology Limited Liability Company
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2025-05-01
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.